Kiniksa Pharmaceuticals
KNSA
#2409
Rank
S$9.62 B
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
S$122.56
Share price
-0.06%
Change (1 day)
128.21%
Change (1 year)

EPS for Kiniksa Pharmaceuticals (KNSA)

EPS in 2026 (TTM): S$1.84

According to Kiniksa Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is S$1.84. In 2025 the company made an earnings per share (EPS) of S$1.03 an increase over its 2024 EPS that were of S-$0.79.

EPS history for Kiniksa Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$1.8477.97%
2025S$1.03-231.15%
2024S-$0.79-421.05%
2023S$0.24-92.8%
2022S$3.40-214.78%
2021S-$2.97-10.85%
2020S-$3.33-14.57%
2019S-$3.896.33%
2018S-$3.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$1.74-194.41%๐Ÿ‡บ๐Ÿ‡ธ USA